Skip to main content

Table 3 Study performance and data element assessment scheme

From: Repetitive transcranial magnetic stimulation (rTMS) for treatment-resistant major depression (TRMD) Veteran patients: study protocol for a randomized controlled trial

Assessment (domain) and specific measurement

Weeks 2–4

Acute treatment phase

Follow-up phase

4–11 weeks

24 weeks

End of session numbera

Taper

Follow up

5

10

15

20

[25]

[30]

1

2

3

4

8

12

16

20

24

Consent

S*

               

Screening

S

               

Randomization

B*

               

Baseline

S

               

Medical history

S

               

Physical exam

S

     

x

         

Laboratory measurements

S

               

SCID-I

S

               

Current/past ATHF

S

               

Lifetime drinking history

B

               

CAPS

B

     

x

        

x

THQ

B

               

LSC-R

B

               

BOMC

S

               

Medication use

S

x

x

x

x

x

x

x

x

x

x

x

x

x

x

x

rTMS treatment log

 

x

x

x

x

x

x

         

rTMS taper log

       

x

x

x

      

HRSD and MADRS

Sb

x

x

x

x

x

x

   

x

x

x

x

x

x

BDI

B

x

x

x

x

x

x

   

x

x

x

x

x

x

QIDS-C16

B

x

x

x

x

x

x

   

x

x

x

x

x

x

C-SSRS

S

               

C-SSRS follow up

 

x

x

x

x

x

x

x

x

x

x

x

x

x

x

x

BSS

S

x

x

x

x

x

x

x

x

x

x

x

x

x

x

x

BHS

S

x

x

x

x

x

x

x

x

x

x

x

x

x

x

x

VR-36

B

     

x

        

x

Neuropsychological battery

B

     

x

        

x

DAST

S

     

x

        

x

PCL

B

     

x

        

x

MAST

S

     

x

        

x

STAXI-2

S

x

x

x

x

x

x

x

x

x

x

x

x

x

x

x

Urine toxicology screen and alcohol test

S

 

x

 

x

 

X

 

x

 

x

 

x

 

x

 

Protocol deviation

As required

AE/SAE/UADE

As required

  1. Note, for primary analyses and descriptive statistics total scores are used. Abbreviations: SCID Structured Clinical Interview for DSM Disorders, ATHF Antidepressant Treatment History Form, CAPS Clinician Administered PTSD Scale, THQ Trauma History Questionnaire, LSC-R Life Stressor Checklist-revised, BOMC Six-Item Blessed Orientation-Memory-Concentration, rTMS Repetitive transcranial magnetic stimulation, HRSD Hamilton Rating Scale for Depression, MADRS Montgomery-Asberg Depression Rating Scale, BDI Beck Depression Inventory, QIDS-C16 Quick Inventory of Depressive Symptomatology, C-SSRS Columbia Suicide Severity Rating Scale, BSS Beck Scale for Suicide Ideation, BHS Beck Hopelessness Scale, VR-36 Veterans RAND 36-Item Health Survey, DAST Drug Abuse Screening Test, PCL Posttraumatic Stress Disorder Checklist, MAST Michigan Alcohol Screening Test, STAXI-2 State Trait Anger Expression Inventory-2, AE adverse events, SAE serious adverse events
  2. *B Baseline
  3. *S Screening
  4. aSessions 21–25 and 26 − 30 may not be required if patient goes into remission earlier
  5. bMust be conducted within 7 days prior to randomization